Clinical trial identifies promising target for liver disease treatments

An international clinical trial involving Birmingham Professor Phil Newsome identified a promising target for patients with non-alcoholic steatohepatitis (NASH), as reported in a paper published yesterday (Nov. 6) in Nature Communications. The research team demonstrated that an oral inhibitor of amine oxidase copper-containing 3 (AOC3)—a protein involved in liver inflammation that can lead to fibrosis, cirrhosis and liver cancer—successfully suppressed this protein and reduced liver injury.

Testing the ways environment can impact the way food or drinks taste

A team of industrial designers and architects and a psychologist at the University of Campania, in Italy, has tested some of the ways that the immediate environment can impact the taste of food or drinks. The group gave a conference presentation outlining their preliminary results last year at the 24th International Congress on Acoustics. They have since published their paper in the journal Food Quality and Preference. In their study, the group asked volunteers in different environmental settings to taste low-sugar orange juice.

CAGE SMUGGLERS

IT is unacceptable that people who are conscious that they are committing a criminal offence could have the audacity to stone uniformed officers of the defence and security wings.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.